TYRA
Tyra Biosciences, Inc.
Company overview
- Market capitalization
- $1.28B
- Employees
- 87
- Latest publication
- 2026-09-29
About Tyra Biosciences, Inc.
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is FGFR3, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for intrahepatic cholangiocarcinoma; and TYRA-430 for the treatment of hepatocellular carcinoma. Tyra Biosciences, Inc. was incorporated in 2018 and is headquartered in Carlsbad, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 496,000USD | 0USD | 0USD |
| Cost Of Revenue | 138,000USD | 132,000USD | — | 140,000USD | 143,000USD | — | 127,000USD | 126,000USD |
| Gross Profit | -138,000USD | -132,000USD | — | -140,000USD | -143,000USD | 248,000USD | -127,000USD | -126,000USD |
| Research Development | 33,332,000USD | 28,186,000USD | 25,469,000USD | 24,309,000USD | 24,964,000USD | 22,180,000USD | 22,697,000USD | 17,871,000USD |
| Selling General Administrative | 8,528,000USD | 8,330,000USD | 7,475,000USD | 7,143,000USD | 6,886,000USD | 7,564,000USD | 5,907,000USD | 5,535,000USD |
| Total Operating Expenses | 41,860,000USD | 36,516,000USD | 32,944,000USD | 31,452,000USD | 31,850,000USD | 29,744,000USD | 28,604,000USD | 23,406,000USD |
| Operating Income | -41,998,000USD | -36,516,000USD | -32,944,000USD | -31,452,000USD | -31,850,000USD | -29,744,000USD | -28,604,000USD | -23,532,000USD |
| Interest Income | 2,693,000USD | 2,682,000USD | 3,076,000USD | 3,354,000USD | 3,703,000USD | 4,173,000USD | 4,588,000USD | 4,830,000USD |
| Net Interest Income | 2,693,000USD | 2,682,000USD | 3,076,000USD | 3,354,000USD | 3,703,000USD | 4,173,000USD | 4,588,000USD | 4,830,000USD |
| Income Before Tax | -39,305,000USD | -33,834,000USD | -29,868,000USD | -28,098,000USD | -28,147,000USD | -25,571,000USD | -24,016,000USD | -18,702,000USD |
| Net Income | -39,305,000USD | -33,834,000USD | -29,868,000USD | -28,098,000USD | -28,147,000USD | -25,571,000USD | -24,016,000USD | -18,702,000USD |
| Net Income From Continuing Ops | -39,305,000USD | -33,834,000USD | -29,868,000USD | -28,098,000USD | -28,147,000USD | -25,571,000USD | -24,016,000USD | -18,702,000USD |
| Ebit | -41,998,000USD | -36,516,000USD | -29,868,000USD | -31,452,000USD | -31,850,000USD | -29,744,000USD | -28,604,000USD | -23,532,000USD |
| Ebitda | -41,860,000USD | -36,384,000USD | -29,737,000USD | -31,312,000USD | -31,707,000USD | -29,600,000USD | -28,477,000USD | -23,406,000USD |
| Depreciation And Amortization | 138,000USD | 132,000USD | 131,000USD | 140,000USD | 143,000USD | 144,000USD | 127,000USD | 126,000USD |
| Reconciled Depreciation | 138,000USD | 132,000USD | 131,000USD | 140,000USD | 143,000USD | 144,000USD | 127,000USD | 126,000USD |
| Total Other Income Expense Net | 2,693,000USD | 2,682,000USD | 3,076,000USD | 3,354,000USD | 3,703,000USD | 4,173,000USD | 4,588,000USD | 4,830,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 546,000USD | 519,000USD | 353,000USD | 296,000USD | 140,000USD | 47,000USD | 8,000USD |
| Gross Profit | -546,000USD | -519,000USD | -353,000USD | -296,000USD | -140,000USD | -47,000USD | -8,000USD |
| Research Development | 102,928,000USD | 80,077,000USD | 62,518,000USD | 43,008,000USD | 20,636,000USD | 7,203,000USD | 1,790,000USD |
| Selling General Administrative | 29,834,000USD | 24,100,000USD | 17,427,000USD | 15,919,000USD | 5,652,000USD | 2,094,000USD | 1,332,000USD |
| Total Operating Expenses | 132,762,000USD | 104,177,000USD | 79,945,000USD | 58,927,000USD | 26,288,000USD | 9,250,000USD | 3,122,000USD |
| Operating Income | -132,762,000USD | -104,177,000USD | -79,945,000USD | -58,927,000USD | -26,288,000USD | -9,297,000USD | -3,122,000USD |
| Interest Income | 12,815,000USD | 17,696,000USD | 10,850,000USD | 3,652,000USD | 13,000USD | — | — |
| Net Interest Income | 12,815,000USD | 17,696,000USD | 10,850,000USD | 3,652,000USD | 13,000USD | -1,000USD | -1,000USD |
| Income Before Tax | -119,947,000USD | -86,481,000USD | -69,134,000USD | -55,325,000USD | -26,294,000USD | -9,336,000USD | -4,065,000USD |
| Net Income | -119,947,000USD | -86,481,000USD | -69,134,000USD | -51,723,000USD | -26,141,000USD | -9,314,000USD | -4,058,000USD |
| Net Income From Continuing Ops | -119,947,000USD | -86,481,000USD | -69,134,000USD | -55,325,000USD | -26,294,000USD | -9,336,000USD | -4,065,000USD |
| Ebit | -132,762,000USD | -104,177,000USD | -79,945,000USD | -58,927,000USD | -26,288,000USD | -9,297,000USD | -3,122,000USD |
| Ebitda | -132,216,000USD | -103,658,000USD | -79,588,000USD | -58,631,000USD | -26,148,000USD | -9,250,000USD | -3,114,000USD |
| Depreciation And Amortization | 546,000USD | 519,000USD | 357,000USD | 296,000USD | 140,000USD | 47,000USD | 8,000USD |
| Reconciled Depreciation | 546,000USD | 519,000USD | 353,000USD | 296,000USD | 140,000USD | 47,000USD | 8,000USD |
| Total Other Income Expense Net | 12,815,000USD | 17,696,000USD | 10,811,000USD | 3,602,000USD | -6,000USD | -39,000USD | -943,000USD |
| Interest Expense | — | — | — | 296,000USD | 140,000USD | 1,000USD | 1,000USD |
| Income Tax Expense | — | — | — | -3,602,000USD | -153,000USD | -22,000USD | -7,000USD |
| Non Operating Income Net Other | — | — | — | 3,602,000USD | -6,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | -55,325,000USD | -26,294,000USD | -9,336,000USD | -4,065,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 383,362,000USD | 412,040,000USD | 282,609,000USD | 301,851,000USD | 321,499,000USD | 343,476,000USD | 363,558,000USD | 380,592,000USD |
| Cash And Equivalents | 73,835,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 366,966,000USD | 394,613,000USD | 265,450,000USD | 281,216,000USD | 302,155,000USD | 324,566,000USD | 347,463,000USD | 365,611,000USD |
| Other Current Assets | 13,022,000USD | 11,147,000USD | 9,447,000USD | 4,092,000USD | 4,184,000USD | 3,823,000USD | 4,022,000USD | 3,581,000USD |
| Other Non Current Assets | 9,028,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 29,698,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 24,620,000USD | 19,256,000USD | 18,094,000USD | 15,879,000USD | 13,770,000USD | 14,246,000USD | 14,594,000USD | 12,373,000USD |
| Total Stockholder Equity | 353,664,000USD | 387,575,000USD | 259,177,000USD | 280,509,000USD | 302,147,000USD | 323,534,000USD | 343,151,000USD | 362,288,000USD |
| Total Equity Including Noncontrolling Interest | 353,664,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 6,484,000USD | 6,658,000USD | 6,887,000USD | 7,045,000USD | 7,235,000USD | 7,468,000USD | 7,719,000USD | 7,975,000USD |
| Accounts Payable | 2,334,000USD | 3,642,000USD | 1,178,000USD | 1,991,000USD | 2,245,000USD | 2,500,000USD | 590,000USD | 1,165,000USD |
| Short Term Debt | 504,000USD | 488,000USD | 472,000USD | 456,000USD | 441,000USD | 426,000USD | 412,000USD | 398,000USD |
| Common Stock | 6,000USD | 6,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD |
| Retained Earnings | -456,121,000USD | -410,563,000USD | -371,258,000USD | -337,424,000USD | -307,556,000USD | -279,458,000USD | -251,311,000USD | -225,740,000USD |
| Accumulated Other Comprehensive Income | -580,000USD | 107,000USD | 393,000USD | 442,000USD | 436,000USD | 688,000USD | 770,000USD | 1,752,000USD |
| Total Liab | — | 24,465,000USD | 23,432,000USD | 21,342,000USD | 19,352,000USD | 19,942,000USD | 20,407,000USD | 18,304,000USD |
| Other Current Liab | — | 15,126,000USD | 16,444,000USD | 13,432,000USD | 11,084,000USD | 11,320,000USD | 13,592,000USD | 10,810,000USD |
| Capital Stock | — | 6,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD |
| Cash | — | 84,955,000USD | 77,387,000USD | 61,951,000USD | 98,490,000USD | 100,721,000USD | 91,966,000USD | 103,892,000USD |
| Cash And Short Term Investments | — | 383,466,000USD | 256,003,000USD | 274,924,000USD | 296,271,000USD | 318,943,000USD | 341,441,000USD | 360,130,000USD |
| Net Debt | — | -79,258,000USD | -71,577,000USD | -56,032,000USD | -92,467,000USD | -94,599,000USD | -85,744,000USD | -97,574,000USD |
| Short Long Term Debt Total | — | 5,697,000USD | 5,810,000USD | 5,919,000USD | 6,023,000USD | 6,122,000USD | 6,222,000USD | 6,318,000USD |
| Short Term Investments | — | 298,511,000USD | 178,616,000USD | 212,973,000USD | 197,781,000USD | 218,222,000USD | 249,475,000USD | 256,238,000USD |
| Property Plant Equipment Gross | — | 6,658,000USD | 6,887,000USD | 7,045,000USD | 7,235,000USD | 8,861,000USD | 9,000,000USD | 9,154,000USD |
| Common Stock Shares Outstanding | — | 61,746,050shares | 59,602,328shares | 59,670,757shares | 59,550,771shares | 59,336,550shares | 58,874,497shares | 58,874,497shares |
| Non Current Assets Total | — | 17,427,000USD | 17,159,000USD | 20,634,999USD | 19,344,000USD | 18,910,000USD | 16,095,000USD | 14,981,000USD |
| Non Current Liabilities Total | — | 5,209,000USD | 5,338,000USD | 5,462,999USD | 5,582,000USD | 5,696,000USD | 5,813,000USD | 5,931,000USD |
| Non Currrent Assets Other | — | 10,769,000USD | 10,272,000USD | 12,589,999USD | 12,109,000USD | 11,442,000USD | 8,376,000USD | 6,006,000USD |
| Net Working Capital | — | 375,357,000USD | 247,356,000USD | 265,337,000USD | 288,385,000USD | 310,320,000USD | 332,869,000USD | 353,238,000USD |
| Unclassified Non Current Liabilities | — | 5,209,000USD | 5,338,000USD | 5,462,999USD | 5,582,000USD | 5,696,000USD | 5,810,000USD | 5,920,000USD |
| Unclassified Equity | — | 798,019,000USD | 630,032,000USD | 617,481,000USD | 609,257,000USD | 602,294,000USD | 593,682,000USD | 586,266,000USD |
| Net Receivables | — | — | — | 2,200,000USD | 1,700,000USD | 1,800,000USD | 2,000,000USD | 1,900,000USD |
| Other Assets | — | — | — | — | — | — | -1,539,000USD | — |
| Non Current Liabilities Other | — | — | — | — | — | — | 3,000USD | 11,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 282,609,000USD | 363,558,000USD | 225,857,000USD | 266,181,000USD | 306,701,000USD | 16,011,000USD | 528,000USD |
| Other Current Assets | 9,447,000USD | 4,022,000USD | 8,202,000USD | 6,075,000USD | 1,875,000USD | 57,000USD | 19,000USD |
| Total Liab | 23,432,000USD | 20,407,000USD | 21,595,000USD | 8,352,000USD | 4,964,000USD | 29,649,000USD | 5,269,000USD |
| Total Stockholder Equity | 259,177,000USD | 343,151,000USD | 204,262,000USD | 257,829,000USD | 301,737,000USD | -13,638,000USD | -4,741,000USD |
| Other Current Liab | 16,444,000USD | 13,592,000USD | 10,391,000USD | 4,416,000USD | 2,815,000USD | 1,052,000USD | 4,689,000USD |
| Common Stock | 5,000USD | 5,000USD | 4,000USD | 4,000USD | 4,000USD | — | — |
| Capital Stock | 5,000USD | 5,000USD | 4,000USD | 4,000USD | 4,000USD | 0USD | 0USD |
| Retained Earnings | -371,258,000USD | -251,311,000USD | -164,830,000USD | -95,696,000USD | -40,371,000USD | -14,077,000USD | -4,741,000USD |
| Cash | 77,387,000USD | 91,966,000USD | 58,006,000USD | 251,213,000USD | 302,182,000USD | 15,224,000USD | 108,000USD |
| Cash And Short Term Investments | 256,003,000USD | 341,441,000USD | 203,469,000USD | 251,213,000USD | 302,182,000USD | 15,224,000USD | 108,000USD |
| Total Current Assets | 265,450,000USD | 347,463,000USD | 211,671,000USD | 257,288,000USD | 304,057,000USD | 15,281,000USD | 127,000USD |
| Total Current Liabilities | 18,094,000USD | 14,594,000USD | 15,333,000USD | 5,701,000USD | 3,616,000USD | 1,858,000USD | 5,155,000USD |
| Net Debt | -71,577,000USD | -85,744,000USD | -51,510,000USD | -248,591,000USD | -300,999,000USD | -15,082,000USD | 145,000USD |
| Short Term Debt | 472,000USD | 412,000USD | 280,000USD | 140,000USD | 202,000USD | 142,000USD | 139,000USD |
| Short Long Term Debt Total | 5,810,000USD | 6,222,000USD | 6,496,000USD | 2,622,000USD | 1,183,000USD | 142,000USD | 253,000USD |
| Short Term Investments | 178,616,000USD | 249,475,000USD | 145,463,000USD | 0USD | — | — | — |
| Accounts Payable | 1,178,000USD | 590,000USD | 4,662,000USD | 1,145,000USD | 599,000USD | 664,000USD | 327,000USD |
| Property Plant Equipment Net | 6,887,000USD | 7,719,000USD | 8,154,000USD | 3,543,000USD | 2,089,000USD | 466,000USD | 276,000USD |
| Property Plant Equipment Gross | 6,887,000USD | 9,000,000USD | 8,961,000USD | 4,004,000USD | 2,089,000USD | 509,000USD | 281,000USD |
| Accumulated Other Comprehensive Income | 393,000USD | 770,000USD | 381,000USD | 0USD | -306,701,000USD | — | — |
| Common Stock Shares Outstanding | 59,602,328shares | 57,217,746shares | 42,704,876shares | 41,883,904shares | 41,441,135shares | 42,535,139shares | 42,535,139shares |
| Non Current Assets Total | 17,159,000USD | 16,095,000USD | 14,186,000USD | 8,893,000USD | 2,644,000USD | 730,000USD | 401,000USD |
| Non Current Liabilities Total | 5,338,000USD | 5,813,000USD | 6,262,000USD | 2,651,000USD | 1,348,000USD | 27,791,000USD | 114,000USD |
| Non Currrent Assets Other | 10,272,000USD | 8,376,000USD | 6,032,000USD | 5,350,000USD | 555,000USD | 21,000USD | 125,000USD |
| Net Working Capital | 247,356,000USD | 332,869,000USD | 196,338,000USD | 251,587,000USD | 300,441,000USD | 13,423,000USD | -5,028,000USD |
| Unclassified Non Current Liabilities | 5,338,000USD | 5,810,000USD | 6,216,000USD | — | — | 27,511,000USD | — |
| Unclassified Equity | 630,032,000USD | 593,682,000USD | 368,703,000USD | 353,517,000USD | 648,801,000USD | — | — |
| Net Receivables | — | 2,000,000USD | 700,000USD | — | — | — | — |
| Non Current Liabilities Other | — | 3,000USD | 46,000USD | 2,651,000USD | 1,348,000USD | 140,000USD | — |
| Other Liab | — | — | — | 169,000USD | 367,000USD | 140,000USD | — |
| Other Assets | — | — | — | 5,350,000USD | 555,000USD | 0USD | 125,000USD |
| Net Tangible Assets | — | — | — | 257,829,000USD | 301,737,000USD | -13,638,000USD | -4,741,000USD |
| Unclassified Non Current Assets | — | — | — | -5,350,000USD | — | — | — |
| Deferred Long Term Liab | — | — | — | — | — | — | 107,000USD |
| Current Deferred Revenue | — | — | — | — | — | — | 364,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -39,305,000USD | -33,834,000USD | -29,868,000USD | -28,098,000USD | -28,147,000USD | -25,571,000USD | -24,016,000USD | -18,702,000USD |
| Depreciation | 138,000USD | 132,000USD | 131,000USD | 140,000USD | 143,000USD | 144,000USD | 127,000USD | 126,000USD |
| Stock Based Compensation | 7,847,000USD | 7,627,000USD | 7,577,000USD | 6,380,000USD | 6,422,000USD | 6,702,000USD | 7,573,000USD | 4,411,000USD |
| Other Non Cash Items | -65,000USD | -126,000USD | -419,000USD | -708,000USD | -866,000USD | -1,183,000USD | -1,605,000USD | -1,867,000USD |
| Change In Working Capital | -1,186,000USD | 2,577,000USD | 199,000USD | -1,394,000USD | -3,010,000USD | 318,000USD | 23,000USD | 5,774,000USD |
| Total Cash From Operating Activities | -32,571,000USD | -23,624,000USD | -22,380,000USD | -23,680,000USD | -25,458,000USD | -19,590,000USD | -17,898,000USD | -10,258,000USD |
| Capital Expenditures | -88,000USD | -57,000USD | -39,000USD | -31,000USD | -14,000USD | -6,000USD | -52,000USD | -470,000USD |
| Free Cash Flow | -32,659,000USD | -23,681,000USD | -22,419,000USD | -23,711,000USD | -25,472,000USD | -19,596,000USD | -17,950,000USD | -10,728,000USD |
| Investments | -120,156,000USD | 34,434,000USD | -14,806,000USD | 20,866,000USD | 32,026,000USD | 6,958,000USD | 21,557,000USD | -144,991,000USD |
| Total Cashflows From Investing Activities | -120,244,000USD | 34,377,000USD | -14,806,000USD | 20,866,000USD | 32,026,000USD | 6,958,000USD | 21,557,000USD | -144,991,000USD |
| Total Cash From Financing Activities | 160,383,000USD | 4,683,000USD | 647,000USD | 583,000USD | 2,187,000USD | 706,000USD | 743,000USD | 373,000USD |
| Issuance Of Capital Stock | 147,853,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Change In Cash | 7,568,000USD | 15,436,000USD | -36,539,000USD | -2,231,000USD | 8,755,000USD | -11,926,000USD | 4,402,000USD | -154,876,000USD |
| Begin Period Cash Flow | 78,387,000USD | 62,951,000USD | 98,490,000USD | 101,721,000USD | 92,966,000USD | 104,892,000USD | 99,490,000USD | 255,366,000USD |
| End Period Cash Flow | 85,955,000USD | 78,387,000USD | 61,951,000USD | 99,490,000USD | 101,721,000USD | 92,966,000USD | 103,892,000USD | 100,490,000USD |
| Other Cashflows From Financing Activities | 160,383,000USD | 4,683,000USD | 647,000USD | — | 2,187,000USD | 706,000USD | 743,000USD | 624,000USD |
| Unclassified Financing Cash Flow | -147,853,000USD | — | — | — | — | — | — | — |
| Sale Purchase Of Stock | — | 0USD | 0USD | 0USD | 0USD | 0USD | 420,000USD | -251,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | -1USD | -144,521USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -119,947,000USD | -86,481,000USD | -69,134,000USD | -55,325,000USD | -26,294,000USD | -9,336,000USD | -4,065,000USD |
| Depreciation | 546,000USD | 519,000USD | 353,000USD | 296,000USD | 140,000USD | 47,000USD | 8,000USD |
| Stock Based Compensation | 28,006,000USD | 22,801,000USD | 13,525,000USD | 10,588,000USD | 2,887,000USD | 439,000USD | 0USD |
| Other Non Cash Items | -2,119,000USD | -5,884,000USD | 12,282,000USD | 3,000USD | 3,000USD | 17,000USD | 934,000USD |
| Change In Working Capital | -1,628,000USD | -729,000USD | 6,360,000USD | -5,847,000USD | -481,000USD | 1,070,000USD | 505,000USD |
| Total Cash From Operating Activities | -95,142,000USD | -69,774,000USD | -50,139,000USD | -50,285,000USD | -23,745,000USD | -7,763,000USD | -2,618,000USD |
| Capital Expenditures | -141,000USD | -664,000USD | -770,000USD | -559,000USD | -661,000USD | -312,000USD | -20,000USD |
| Free Cash Flow | -95,283,000USD | -70,438,000USD | -50,909,000USD | -50,844,000USD | -24,406,000USD | -8,075,000USD | -2,638,000USD |
| Investments | 72,604,000USD | -98,403,000USD | -144,605,000USD | -559,000USD | -645,000USD | -312,000USD | -20,000USD |
| Total Cashflows From Investing Activities | 72,463,000USD | -98,403,000USD | -144,605,000USD | -559,000USD | -645,000USD | -312,000USD | -20,000USD |
| Total Cash From Financing Activities | 8,100,000USD | 202,137,000USD | 1,537,000USD | 632,000USD | 311,348,000USD | 23,434,000USD | 157,000USD |
| Sale Purchase Of Stock | 0USD | -420,000USD | 0USD | — | 311,382,000USD | — | — |
| Issuance Of Capital Stock | 0USD | 200,000,000USD | 0USD | 181,336,000USD | 310,843,000USD | 23,311,000USD | 0USD |
| Change In Cash | -14,579,000USD | 33,960,000USD | -193,207,000USD | -50,969,000USD | 286,958,000USD | 15,359,000USD | -2,481,000USD |
| Begin Period Cash Flow | 92,966,000USD | 59,006,000USD | 251,213,000USD | 302,182,000USD | 15,467,000USD | 108,000USD | 2,589,000USD |
| End Period Cash Flow | 78,387,000USD | 92,966,000USD | 58,006,000USD | 251,213,000USD | 302,425,000USD | 15,467,000USD | 108,000USD |
| Other Cashflows From Financing Activities | 8,100,000USD | 2,557,000USD | 1,537,000USD | 632,000USD | 130,137,000USD | 23,451,000USD | 165,000USD |
| Unclassified Financing Cash Flow | — | 200,000,000USD | — | -181,336,000USD | -130,146,000USD | -23,311,000USD | — |
| Unclassified Operating Cash Flow | — | — | -13,525,000USD | — | — | — | — |
| Change To Liabilities | — | — | — | 2,357,000USD | 1,492,000USD | 1,019,000USD | 461,000USD |
| Net Borrowings | — | — | — | 0USD | -25,000USD | -17,000USD | -8,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -50,212,000USD | 286,958,000USD | — | — |
| Other Cashflows From Investing Activities | — | — | — | — | 16USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.